Development of a radioreceptor assay for measuring an oxytocin antagonist in blood

T.H. An; C.H. Song; Sokcheon Pak; B.C. Choi; L. Diveky; G. Flouret

doi:10.1159/000074822

Development of a radioreceptor assay for measuring an oxytocin antagonist in blood

T.H. An, C.H. Song, Sokcheon Pak, B.C. Choi, L. Diveky, G. Flouret

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

The purpose of the present study was to develop a radioreceptor assay to monitor the pharmacokinetics of the oxytocin antagonist, TT-235, in the blood of the pregnant rat and baboon. The receptors used for this assay were prepared from the pregnant rat uterus at delivery. The assay using blood from pregnant rats and baboons was performed on filter plates and analyzed for radioactivity in a gamma counter. The assay was sensitive to 10 pg/well with a range from 10 to 1,000 pg. The average recovery was 86%. A new radioreceptor assay was developed for the oxytocin antagonist, TT-235. TT-235 had a much longer half-life than oxytocin in the pregnant rat and baboon. This longer half-life may partially explain the prolonged in vivo tocolytic activity of TT-235 in these animals.

Original language	English
Pages (from-to)	213-217
Number of pages	5
Journal	Gynecologic and Obstetric Investigation
Volume	56
Issue number	4
DOIs	https://doi.org/10.1159/000074822
Publication status	Published - 2003

Access to Document

10.1159/000074822

Cite this

@article{c72d8bfc7d604bdebcc2ea60afaf5444,

title = "Development of a radioreceptor assay for measuring an oxytocin antagonist in blood",

abstract = "The purpose of the present study was to develop a radioreceptor assay to monitor the pharmacokinetics of the oxytocin antagonist, TT-235, in the blood of the pregnant rat and baboon. The receptors used for this assay were prepared from the pregnant rat uterus at delivery. The assay using blood from pregnant rats and baboons was performed on filter plates and analyzed for radioactivity in a gamma counter. The assay was sensitive to 10 pg/well with a range from 10 to 1,000 pg. The average recovery was 86%. A new radioreceptor assay was developed for the oxytocin antagonist, TT-235. TT-235 had a much longer half-life than oxytocin in the pregnant rat and baboon. This longer half-life may partially explain the prolonged in vivo tocolytic activity of TT-235 in these animals.",

author = "T.H. An and C.H. Song and Sokcheon Pak and B.C. Choi and L. Diveky and G. Flouret",

note = "Imported on 12 Apr 2017 - DigiTool details were: Journal title (773t) = Gynecologic and Obstetric Investigation. ISSNs: 0378-7346; ",

year = "2003",

doi = "10.1159/000074822",

language = "English",

volume = "56",

pages = "213--217",

journal = "Gynecologic and Obstetric Investigation",

issn = "0378-7346",

publisher = "S Karger AG",

number = "4",

}

TY - JOUR

T1 - Development of a radioreceptor assay for measuring an oxytocin antagonist in blood

AU - An, T.H.

AU - Song, C.H.

AU - Pak, Sokcheon

AU - Choi, B.C.

AU - Diveky, L.

AU - Flouret, G.

N1 - Imported on 12 Apr 2017 - DigiTool details were: Journal title (773t) = Gynecologic and Obstetric Investigation. ISSNs: 0378-7346;

PY - 2003

Y1 - 2003

N2 - The purpose of the present study was to develop a radioreceptor assay to monitor the pharmacokinetics of the oxytocin antagonist, TT-235, in the blood of the pregnant rat and baboon. The receptors used for this assay were prepared from the pregnant rat uterus at delivery. The assay using blood from pregnant rats and baboons was performed on filter plates and analyzed for radioactivity in a gamma counter. The assay was sensitive to 10 pg/well with a range from 10 to 1,000 pg. The average recovery was 86%. A new radioreceptor assay was developed for the oxytocin antagonist, TT-235. TT-235 had a much longer half-life than oxytocin in the pregnant rat and baboon. This longer half-life may partially explain the prolonged in vivo tocolytic activity of TT-235 in these animals.

AB - The purpose of the present study was to develop a radioreceptor assay to monitor the pharmacokinetics of the oxytocin antagonist, TT-235, in the blood of the pregnant rat and baboon. The receptors used for this assay were prepared from the pregnant rat uterus at delivery. The assay using blood from pregnant rats and baboons was performed on filter plates and analyzed for radioactivity in a gamma counter. The assay was sensitive to 10 pg/well with a range from 10 to 1,000 pg. The average recovery was 86%. A new radioreceptor assay was developed for the oxytocin antagonist, TT-235. TT-235 had a much longer half-life than oxytocin in the pregnant rat and baboon. This longer half-life may partially explain the prolonged in vivo tocolytic activity of TT-235 in these animals.

U2 - 10.1159/000074822

DO - 10.1159/000074822

M3 - Article

SN - 0378-7346

VL - 56

SP - 213

EP - 217

JO - Gynecologic and Obstetric Investigation

JF - Gynecologic and Obstetric Investigation

IS - 4

ER -

Development of a radioreceptor assay for measuring an oxytocin antagonist in blood

Abstract

Access to Document

Fingerprint

Cite this